| The Austrian Paradoxical Cerebral Embolism Trial
|
TACET |
N/A |
 |
| Wingspan Stenting for Symptomatic Severe Stenosis of Intracranial Atherosclerosis Registry in China |
WingspanSSIR |
N/A |
 |
| Stent-assisted Angioplasty of the Offending Intracranial Stenosis plus Optimal Medical Therapy versus Optimal Medical Therapy Alone
|
ASSIST II |
N/A |
|
| A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin |
|
2 |
|
| A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke |
|
3 |
|
| Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) |
|
4 |
|
| Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke |
TARDIS |
N/A |
|
| Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis |
AMTEC |
4 |
|
| Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever |
SNIF |
N/A |
 |
| A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
PLATO |
3 |
|
| Cervical Artery Dissection In Stroke Study: Feasibility Phase. |
CADISS |
N/A |
|
| The Indian POLYCAP Study (TIPS) |
|
N/A |
|
| Antiplatelet therapy in combination with Recombinant t-PA Thrombolysis in Ischemic Stroke. |
ARTIS |
N/A |
|
| EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA |
|
4 |
|
| Aspirin in Reducing Events in the Elderly |
ASPREE |
4 |
|
| Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) |
|
2/3 |
|
| Patent Foramen Ovale in Cryptogenic Stroke Study |
PICSS |
4 |
|
| The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial |
ESCAPE |
4 |
|
| Aspirin Or Warfarin To Prevent Stroke |
|
3 |
|
| PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage |
PICASSO |
4 |
|
| Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event. |
Aspirin |
N/A |
|
| Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection |
|
1 |
 |
| Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions |
CAVAD |
4 |
|
| Chronotherapy With Low-dose Aspirin for Primary Prevention |
CARING |
4 |
|
| Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) |
|
2 |
|
| Antiplatelet Therapy to Prevent Stroke in African Americans |
|
4 |
|
| Patent Foramen Ovale in Cryptogenic Stroke Study |
PICSS |
4 |
|
| Secondary Prevention of Small Subcortical Strokes Trial |
SPS3 |
3 |
|
| Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial |
WARCEF |
3 |
|
| Recurrent Carotid Stenosis |
|
2 |
|
| Japanese Primary Prevention Project With Aspirin |
|
4 |
|
| COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke |
COMPRESS |
4 |
|
| Aspirin Prophylaxis in Sickle Cell Disease |
START |
1/2 |
|
| Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) |
|
3 |
|
| ASCEND: A Study of Cardiovascular Events iN Diabetes |
|
4 |
|
| Cilostazol in Acute Ischemic Stroke Treatment (CAIST) |
|
4 |
|
| Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler |
ECLIPse |
4 |
|
| Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence |
CLOSE |
3 |
|
| Study of Aspirin and TPA in Acute Ischemic Stroke |
|
1 |
 |
| Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial |
|
4 |
|
| The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation |
|
4 |
|
| Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke |
AHSCTIS |
1 |
|
